Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance01:23

Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance

239
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
239
Antiasthma Drugs: Methylxanthines01:24

Antiasthma Drugs: Methylxanthines

312
Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
312
Physical Properties of Amines01:26

Physical Properties of Amines

3.4K
Amines with low molecular weight are usually gaseous at room temperature, while those with high molecular weight are liquid or solids in nature. Usually, low molecular weight amines have a rotten fish-like smell. Diamines typically have a pungent smell. For instance, cadaverine and putrescine, depicted in Figure 1, are two molecules responsible for decaying tissue.
3.4K
Adrenergic Agonists: Mixed-Action Agents01:28

Adrenergic Agonists: Mixed-Action Agents

807
Mixed-action adrenergic agonists, like ephedrine and pseudoephedrine, directly and indirectly affect adrenergic receptors. These agents stimulate adrenoceptors and indirectly release stored neurotransmitters, amplifying the adrenergic response.
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
807
Adrenergic Agonists: Chemistry and Structure-Activity Relationship01:16

Adrenergic Agonists: Chemistry and Structure-Activity Relationship

3.2K
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
3.2K
Stimulants01:29

Stimulants

265
Stimulants are substances that enhance neural activity and elevate dopamine levels in the brain, leading to their highly addictive nature. These drugs include cocaine, amphetamines, MDMA, caffeine, and nicotine, each with distinct mechanisms of action and varied health implications.
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
265

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evidence in practice: implementing KAT in indigenous health services.

Frontiers in psychiatry·2026
Same author

Decoding the Longevity Networks of the Mediterranean Diet: Systems Biology and Multi-Pathway Mechanisms Shaping Healthspan.

International journal of molecular sciences·2026
Same author

Editorial: Psychedelic-assisted psychotherapies: from clinical trials to credibility.

Frontiers in neuroscience·2026
Same author

A randomized, triple-blind, placebo-controlled, parallel study of the efficacy of D-mannose for urinary tract infection symptoms in women.

Current urology·2026
Same author

A Randomized, Triple-Blind, Placebo-Controlled, Parallel Clinical Trial Investigating Safety and Efficacy of Corn Leaf Extract on Sleep Quality in a Healthy Population With Difficulty Falling or Staying Asleep.

Food science & nutrition·2026
Same author

Almond Consumption on HDL Cholesterol and CVD Risk Factors in Adults with High Cholesterol: A Randomized, Comparator-Controlled Trial.

Journal of medicinal food·2025

Related Experiment Video

Updated: Aug 9, 2025

Caffeine Extraction, Enzymatic Activity and Gene Expression of Caffeine Synthase from Plant Cell Suspensions
09:11

Caffeine Extraction, Enzymatic Activity and Gene Expression of Caffeine Synthase from Plant Cell Suspensions

Published on: October 2, 2018

12.8K

Paraxanthine safety and comparison to caffeine.

Sandra K Szlapinski1, Andrew Charrette1, Najla Guthrie1

  • 1KGK Science Inc, Division of Client Services, Department of Regulatory Affairs, London, ON, Canada.

Frontiers in Toxicology
|February 23, 2023
PubMed
Summary

Paraxanthine, a caffeine metabolite, shows no genetic toxicity and a higher no observed adverse effect level (NOAEL) than caffeine in rat studies. These findings suggest paraxanthine may be a safer stimulant alternative for human consumption.

Keywords:
1,7-dimethylxanthinecaffeinemethylxanthineparaxanthinepreclinicalrodentsafety assessmenttoxicology assessment

More Related Videos

Assaying β-amyloid Toxicity using a Transgenic C. elegans Model
13:59

Assaying β-amyloid Toxicity using a Transgenic C. elegans Model

Published on: October 9, 2010

26.0K
Color Spot Test As a Presumptive Tool for the Rapid Detection of Synthetic Cathinones
06:06

Color Spot Test As a Presumptive Tool for the Rapid Detection of Synthetic Cathinones

Published on: February 5, 2018

24.8K

Related Experiment Videos

Last Updated: Aug 9, 2025

Caffeine Extraction, Enzymatic Activity and Gene Expression of Caffeine Synthase from Plant Cell Suspensions
09:11

Caffeine Extraction, Enzymatic Activity and Gene Expression of Caffeine Synthase from Plant Cell Suspensions

Published on: October 2, 2018

12.8K
Assaying β-amyloid Toxicity using a Transgenic C. elegans Model
13:59

Assaying β-amyloid Toxicity using a Transgenic C. elegans Model

Published on: October 9, 2010

26.0K
Color Spot Test As a Presumptive Tool for the Rapid Detection of Synthetic Cathinones
06:06

Color Spot Test As a Presumptive Tool for the Rapid Detection of Synthetic Cathinones

Published on: February 5, 2018

24.8K

Area of Science:

  • Toxicology
  • Pharmacology
  • Food Science

Background:

  • Caffeine is a widely consumed stimulant with known side effects.
  • Paraxanthine is the primary human metabolite of caffeine, sharing similar stimulant properties.
  • There is a need to investigate safer stimulant alternatives to caffeine.

Purpose of the Study:

  • To evaluate the toxicity of paraxanthine compared to caffeine.
  • To assess paraxanthine's potential as a safer alternative stimulant.

Main Methods:

  • Conducted a battery of toxicological studies on paraxanthine according to international guidelines.
  • Assessed mutagenicity (bacterial reverse mutation, in vitro mammalian chromosomal aberration) and genetic toxicity (in vitro mammalian cell gene mutation).
  • Evaluated acute, sub-acute (14-day), and sub-chronic (90-day) oral toxicity in Sprague Dawley rats.

Main Results:

  • Paraxanthine exhibited no evidence of genetic toxicity or mutagenicity in in vitro studies.
  • An acute oral LD50 for paraxanthine was established at 829.20 mg/kg body weight.
  • In 90-day studies, the no observed adverse effect level (NOAEL) was 150 mg/kg bw for caffeine and 185 mg/kg bw for paraxanthine, with no mortality in paraxanthine groups.

Conclusions:

  • Paraxanthine demonstrates a favorable safety profile compared to caffeine in rodent toxicity studies.
  • The higher NOAEL and lack of adverse effects suggest paraxanthine's potential as a safer stimulant alternative.
  • Further research is warranted for widespread incorporation into food and beverages.